Trying to understand the biological need underlying the ability of AML CD34+cells-derived exosomes to bind to E-selectin- ergo targeting endothelial cells-the answer can be found in the cargo of these exosomes that will be delivered to their target cells. Here, CD34 is linked to acute myeloid leukemia.